Engineered antibodies could have a role in regenerative medicine
Engineered antibodies have been shown to potently and specifically activate regenerative pathways in cells. It is possible that these engineered antibodies may form the basis of a new class of therapeutics in the regenerative medicine field.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>